Game Delayed: Lessons from the Project Parking Lot. Joy T. Barnitz, Ph.D. PMP* and Brian D. Livingston, Ph.D. PMP*
|
|
- Muriel Bradley
- 5 years ago
- Views:
Transcription
1 Game Delayed: Lessons from the Project Parking Lot Joy T. Barnitz, Ph.D. PMP* and Brian D. Livingston, Ph.D. PMP* Global Challenges: Succeeding with Distributed Project Teams PMI Silicon Valley Symposium October 8-9, 2011 *Statements reflect the opinions and experiences of the speakers and are not statements on behalf of MedImmune or AstraZeneca 1 Key Learning Objectives New product development in a rapidly evolving biopharmaceutical R&D environment Maintaining focus on the business objectives while meeting changing business requirements and priorities Case study demonstrating the application of key project management monitoring and close out processes to maintain transparent communication and decision making 2 1
2 In the Beginning. Project team Target product profile Timeline Budget 3 On the Mark. Get Ready. Go!! 4 2
3 And Then. CHANGE happens Business environment Competition Technical issues 5 Parked! Looking out to the goal What can we do? What lessons can we learn? How do we adapt to the change? 6 3
4 The Journey A perspective of the vaccine business A brief review of biopharma product development Case #1 MediVax A Case #2 MediVax B Key takeaways 7 Why Vaccines? Vaccines are widely attributed to increase life expectancies The incidence of several life threatening diseases have plummeted Markets for vaccines have grown substantially in the last 30 years Annual vaccine sales have gone from ~$1 billion in 1980 to >$30 billion today Eurosurveillance, Volume 15, Issue
5 Barriers to Vaccine Development Vaccines must be absolutely safe Treatment of healthy individuals necessitates the expectation of do no harm Escalating development time and cost Increased manufacturing costs and larger clinical trials Patience acceptance Education on role in public health Increasing time and economic demands Financing the Delivery of Vaccines MC Lindley et al., Pediatrics, A Project Management Perspective of the Vaccine Business Case Strengths Historic Successes Innovative Technologies Improving Heath = Cost Savings Weaknesses Expensive and lengthy R&D Process High Cost to Entry Market Consolidation Opportunities New Disease Targets Improvement of Existing Vaccines Changing Demographics Threats Anti-Vaccine Movement Developing World Accessibility Adequate Preparedness 10 5
6 Managing Weaknesses by Balancing the Triple Constraint Cost: Budget management Clarity of purpose Establishing expectations Time Organizational education Innovation in project plans Definition of decision points Scope Verification of requirements Managing change 11 Criticality of Clear Communications I know that you believe you understand what you think I said, but I'm not sure you realize that what you heard is not what I meant. Robert McCloskey 12 6
7 The Journey A bit about the vaccine business A brief review of biopharma product development Case #1 MediVax A Case #2 MediVax B Key takeaways 13 New Product Development Innovation is messy Individuals voice ideas Teams make ideas into products Complex interactions & multiple languages Different professions Different experiences Builds a corporate culture and depends on corporate culture 14 7
8 Governance: Choices and Decisions IND NDA DISCOVERY RESEARCH PRE-CLINICAL PRECLINICAL DEVELOPMENT CLINICAL DEVELOPMENT LAUNCH PRODUCT 15 Team Research & Translational Sciences Commercial & Business Project Leader, Project Manager & Regulatory CMC Clinical 16 8
9 The Journey A bit about the vaccine business A brief review of biopharma product development Case #1 MediVax A Case #2 MediVax B Key takeaways 17 MediVaxA: Fast Track! $ $ IND Target Evaluation DISCOVERY RESEARCH Lead Optimization Preclinical Development PRE-CLINICAL DEVELOPMENT 18 9
10 MediVaxA Key Acceleration Factor: Collaboration Experience and expertise 1. Key Opinion Leaders as part of the expanded team from the beginning 2. Partnership with company providing key product component 3. Product process development & product characterization leveraged global development expertise 4. Leveraged historical experience for reasons to believe 19 MediVaxA Key Acceleration Factor: Documentation Stage appropriate 1.Target Product Profile (TPP ) 2.Workplans 3.Timelines 4.Budget 20 10
11 Change Happens Corporate revenue Competitive environment R&D priorities shift Project takes a detour slows down... and parks! 21 MediVaxA: view from the parking lot 1. What can be paused? Complete prototype materials and testing Pause further development and implementation 2. How maintain relationships? Maintain team cohesion and motivation through focus on value proposition Partnerships and vendors Develop options with reduced scope ($, time) to generate data for business partnerships 22 11
12 The Journey A bit about the vaccine business A brief review of biopharma product development Case #1 MediVax A Case #2 MediVax B Key takeaways 23 Early stage projects Research stage projects often appear to be moving slowly What training for project team members can help? How can standard PM tools and techniques help to focus work and communicate progress? 24 12
13 Continuous Improvement Objectives PLAN COMMUNICATE the Plan MONITOR results DO the work W. Edwards Deming 25 MediVaxB: Key Project Factors Commercial Opportunity / Medical Need / Constraints No commercial vaccine Current therapies are not completely effective Selection of target population critical Efficient clinical development Faster time to market / lower costs Technical Complexity HIGH >2 components to produce and characterize longer time in Research stage Higher COGs than previous vaccine pipeline products Lack of predictive animal models 26 13
14 MediVaxB: Approaches & Applications Roles and Responsibilities (RACI) Governance bodies Functional management Team leadership (scientific, PM) Team members Workplans Define deliverables Identify the work, dependencies and durations Timelines, budgets and resources (people & equipt.) Flexible application of standard processes & tools Ex. Risk registers to identify and communicate technical hurdles and identify contingencies and workarounds Ex. Engage early with clinical, commercial and CMC experts 27 MediVaxB: work in - progress Reason to believe demonstrated Multiple technical approaches Component production feasible Streamlined clinical plan proposed Refined TPP in place Milestone review scheduled 28 14
15 MediVaxB: Continuity Through Change Business strategy changes Partnerships emphasized What stays the same? TPP remains same value proposition Data package for internal & external investment decisions What must change? Refine clinical strategy to select target population Adjust data packages / technical approach(es) for specific partners 29 Key Takeaway: Maintain Focus on Goal Business value is to deliver new medicine to patients: has the value proposition changed? Partnering with more than one other corporation: how do communication patterns change? The fox knows many things, but the hedgehog knows one big thing New stakeholders & new opportunities: who are our new collaborators? what new capabilities are available? Achilochus, ancient Greek poet 30 15
16 Organizational Benefits Lessons Learned and Confirmed Experience producing novel proteins Experience with multi-component products Experience with governance processes with external stakeholders Corporate Capabilities Experience with a variety production systems Experience on identifying critical product attributes for novel products 31 Putting It All Together COMMUNICATE Channels of communication may change Complexity may increase Emphasize continuity COLLABORATE Focus on linking team members to achieve key objectives Clearly state requests to stakeholders COORDINATE Change control Risk identification & mitigation Project documentation & history 32 16
17 Acknowledgements R&D Project Management Aida Bendt Jennifer Gribskov Panackal Brian Jennings Simon Lennard Ray Shackelford Julie Sharp Julia Thompson Uwe Huedepohl Key Resources Jared Cohen Mark Esser Laurie Hill Lisa Kreppel Phyllis Link Mike Washabaugh The Teams - CALIFORNIA Muralidhara Bilikallahalli Martin Chandler Greg Duke Chris Frantz Julie Hang Greg Hayes Joe Horwitz Simon Hsu Stacie Lambert Yi Liu Jason Marshall Michael J. McCarthy Louise McCormick Kirsten Schneider-Ohrum Kuldip Sra Elizabeth Stillman Roderick Tang Jennifer Woo Weiguo Zhai Fengrong Zuo The Teams - MARYLAND Brian Bishop Joelle Blakaitis Judy Falloon Bob Gasser Deb Neivert Kellie Ryan Joe Sliman Frank Sifakis Therese Takas 33 17
Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission
Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationHealth Innovations in Horizon 2020: the framework programme for research and innovation ( )
Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationPromoting Patient and Researcher Engagement with Distributed Data Research Networks through Hurdle Free Tools
Promoting Patient and Researcher Engagement with Distributed Data Research Networks through Hurdle Free Tools pscanner All Hands Symposium 2016 Kari A. Stephens, PhD Psychiatry & Behavioral Sciences Biomedical
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationRegulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise
Regulatory Science and Innovation: FDA s Role in Transformation of the MCM Enterprise Jesse L. Goodman, MD, MPH Chief Scientist and Deputy Commissioner for Science and Public Health (Acting), presentation
More information9 Vaccine SMEs' Needs
9 Vaccine SMEs' Needs As in most innovative sectors, SMEs play a critical role in bridging basic discoveries from academic research to clinical development 36. This could be seen over the last decade with
More informationThe Transition to Model-Based Drug Development. Phase 1: Formalizing the Pharmacometric Process
1780 Wehrle Drive Suite 110 Buffalo, New York 14221 716.633.3463 cognigencorp.com The Transition to Model-Based Drug Development Phase 1: Formalizing the Pharmacometric Process By Thaddeus H. Grasela,
More informationFDA Centers of Excellence in Regulatory and Information Sciences
FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationHealth Innovation Manchester
Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing
More informationNational Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs
National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs Jeff Shuren Director, CDRH Food and Drug Administration Center for Devices and Radiological Health 1 We face a critical public
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationWhere the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
More informationDriving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif
Connect and Catalyse Medicines and Healthcare the Global perspective (+10 years) Zahid Latif % GDP spent on health OECD countries spent nearly $3.5trn in 2005 ($4.6 trillion in 2008) on healthcare services
More informationStrategic Plan Approved by Council 7 June 2010
Strategic Plan Approved by Council 7 June 2010 Core Mission The purpose of the American Geophysical Union is to promote discovery in Earth and space science for the benefit of humanity. Core Principles
More informationJUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
More informationIntellectual Property, Vaccine Production and Technology Transfer
Intellectual Property, Vaccine Production and Technology Transfer Vaccine Industry Perspective P. Fournier, On behalf of IFPMA Bio Group 19-20 April 2004, WHO HQ, Geneva 1 OUTLINE General considerations
More informationERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities
ERDF Stakeholder Workshop 4 th May 2016: Overview and Priorities Paul Witcombe Enterprise and Innovation Manager Hertfordshire LEP Email: paul.witcombe@hertfordshirelep.co.uk Tel: 07500 882000 STRUCTURE
More informationInnovative Approaches in Collaborative Planning
Innovative Approaches in Collaborative Planning Lessons Learned from Public and Private Sector Roadmaps Jack Eisenhauer Senior Vice President September 17, 2009 Ross Brindle Program Director Energetics
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationLeader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
More informationInnovation for Defence Excellence and Security (IDEaS)
ASSISTANT DEPUTY MINISTER (SCIENCE AND TECHNOLOGY) Innovation for Defence Excellence and Security (IDEaS) Department of National Defence November 2017 Innovative technology, knowledge, and problem solving
More informationIATA Proprietary. Checkpoint of the Future. .A Risk-based Approach to. Passenger Screening. ICAO Regional Seminar on Aviation Security May 2012
Checkpoint of the Future.A Risk-based Approach to Passenger Screening ICAO Regional Seminar on Aviation Security May 2012 Making a case for change Evolving threat Increased number of passengers 16 Billion
More informationSTRATEGIC FRAMEWORK Updated August 2017
STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK The UC Davis Library is the academic hub of the University of California, Davis, and is ranked among the top academic research libraries in North
More informationThe University of Nairobi is therefore keen to make a follow up on specifics contained in your deliberations.
DVC-RPE Grand Challenges Explorations/BILL & MELINDA GATES Speech The Deputy Vice-Chancellor, Academic Affairs Bill & Melinda Gates Management Team Grand Challenges Explorations Team College Principals
More informationPre-clinical Development Support Services
Pre-clinical Development Support Services Enabling device development with unique understanding Our Company - Vascular Flow Technologies Vascular Flow Technologies (VFT) has evolved from a tiny surgeon
More informationTransforming Consumer and Health-Oriented Society through Science and Innovation. SBRA meeting 20 June 2018
OPEN INNOVATION TEST BEDS - Nanotech and Advanced Materials Transforming Consumer and Health-Oriented Society through Science and Innovation Søren BØWADT-Deputy Head of Unit Advanced Materials and Nanotechnologies
More informationElements in decision making / planning 4 Decision makers. QUESTIONS - stage A. A3.1. Who might be influenced - whose problem is it?
A Describe the CONTEXT, setup the BASELINE, formulate PROBLEMS, identify NEEDS A.. What is the context, the baseline and are the key problems? A.. What are the urgent priorities herein? A.. How would you
More informationScottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund
Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationLundbeck s view on the EU IP systems
Lundbeck s view on the EU IP systems Forårsmøde IPR in the EU May 26 2011 H. Lundbeck A/S 1 Agenda The Innovative Pharmaceutical Industry and why IP is so important for Lundbeck Lundbeck s wish list for
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationParkinson s World A transformational project by The Cure Parkinson s Trust
Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication
More informationPROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS
PRESS RELEASE FOR IMMEDIATE RELEASE PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS US $80 million (CAD $100 million) line of credit secured from Structured Alpha LP Plasminogen BLA
More informationBoard of Directors Meeting In Person June 27 and 28, Vancouver, BC
Board of Directors Meeting In Person June 27 and 28, 2017 Vancouver, BC Attendees:,,,,, Tim Ford,,, Board Attendance via remote audio/video:,, Jordan Goldmeier PASSHQ Attendees: Judy Christianson, Sandy
More informationAuthors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry
Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL
More information25 th Workshop of the EURORDIS Round Table of Companies (ERTC)
25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00
More informationNational Coordinated Registry Network (CRN) Think-tank
National Coordinated Registry Network (CRN) Think-tank The Value of Real World Data for Innovation within FDA What can CRNs offer? Murray Sheldon, MD Associate Director for Technology and Innovation FDA/CDRH
More informationACCELERATING TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017
ACCELERATING TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017 TECHNOLOGY VISION FOR AEROSPACE AND DEFENSE 2017: THROUGH DIGITAL TURBULENCE A powerful combination of market trends, technology developments
More informationThe Foundry Model is Coming to Molecular Diagnostics, Courtesy of the Semiconductor Industry.
The Foundry Model is Coming to Molecular Diagnostics, Courtesy of the Semiconductor Industry. By Wayne Woodard Executive Synopsis In 1981, in a lab on the campus of the University of Southern California,
More informationInnovation-Based Economic Development Strategy for Holyoke and the Pioneer Valley
Massachusetts Technology Collaborative John Adams Innovation Institute Innovation-Based Economic Development Strategy for Holyoke and the Pioneer Valley Innovation District Task Force Meeting October 27,
More informationSynergies and Complementarities with EU Research & Innovation Policy
Synergies and Complementarities with EU Research & Innovation Policy Information Day - EIT 2014 Bernard Mulligan Petra Leroy Cadova Peter Wintlev-Jensen European Commission Budapest, 14 March 2014 Why
More information'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint
'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint STOA workshop - European Parliament, 10 January 2019 Presented
More informationResearch and Innovation in the Defense Health Agency
Research and Innovation in the Defense Health Agency RADM Mary C. Riggs Deputy Assistant Director DHA Research & Development (J-9) 28 November 2018 Disclosures Presenter has no conflict of interest to
More informationGetting from Knowledge to Action: Effectively communicating Research & Development value to multiple Stakeholder Groups.
Getting from Knowledge to Action: Effectively communicating Research & Development value to multiple Stakeholder Groups. Joseph Lane & John Westbrook RESNA - 2010 Presenter Background Joe Lane, MBPA Center
More informationWMD Events and Other Catastrophes
WMD Events and Other Catastrophes 2012 Joint CBRN Conference National Defense Industrial Association March 13, 2012 Tara O Toole, M.D., M.P.H. Under Secretary for Science and Technology U.S. Department
More informationNMP & Health H calls - short overview
Ministry of Science Technology & Space המינהלת הישראלית למו"פ האירופי The Israel-Europe R&D Directorate NMP & Health H2020 2015 calls - short overview Dr. Nili Mandelblit & Ayala Karniol ISERD UK-Israel
More informationDigital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
More informationStrategic Foresight Initiative 2011 Summary Briefing
Strategic Foresight Initiative 2011 Summary Briefing December 2011 Page 1 Today s Session Overview of the Strategic Foresight Initiative (SFI) Research and Stakeholder Engagements Findings and Insights
More informationCelebrating International Women's Day Friday, March 8, :30am-1:00pm
Co-Hosted by: Join us in Launching the 1st Annual Successful Women of San Diego Executive Leadership Panel Celebrating International Women's Day Friday, March 8, 2019 11:30am-1:00pm Sponsored by: Location:
More informationEvolution of Research Consortia Increasing Clinical Focus
1 July 11, 2015 Evolution of Research Consortia Increasing Clinical Focus Elekta Synergy Research Partnerships Lead to development of Synergy Systems Served as model for other technology research groups
More information21st Century R&D Leadership: The Right Medicine?
21st Century R&D Leadership: The Right Medicine? Joe de Sousa Science & Technology Lead, Pharmaceutical Development, AstraZeneca Cambridge July 2016 V4 01 Jul 16 21st Century R&D Leadership: The Right
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More informationCDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC
More informationIndustrial Innovation Information Days Brussels 3-4 October 2017
Industrial Innovation Information Days Brussels 3-4 October 2017 NMBP Programme Parallel Sessions OPEN INNOVATION TEST BEDS Calls 2018/2019 Helene CHRAYE, HoU Unit D3 DG Research & Innovation A joint presentation
More informationKT for TT Ensuring Technologybased R&D matters to Stakeholders. Center on Knowledge Translation for Technology Transfer University at Buffalo
KT for TT Ensuring Technologybased R&D matters to Stakeholders Center on Knowledge Translation for Technology Transfer University at Buffalo Session Objectives 1. Define KT and describe how Models, Methods
More informationMike Hess Vice President, Innovation Medtronic Inc
Mike Hess Vice President, Innovation Medtronic Inc Medtronic Today World headquarters Minneapolis European headquarters Lausanne Asia/Pacific headquarters Singapore $40-60 Billion market capitalization
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationSelecting, Developing and Designing the Visual Content for the Polymer Series
Selecting, Developing and Designing the Visual Content for the Polymer Series A Review of the Process October 2014 This document provides a summary of the activities undertaken by the Bank of Canada to
More information"Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration" Final version
Page 1 of 5 Call for Proposals for "Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration" Final version January 2016 Submission deadline for proposals: 10 th March
More informationDecember Rules for Digital-Proofing Your Technology Strategy
December 2017 5 Rules for Digital-Proofing Your Technology Strategy AT A GLANCE No development in modern times has been as pervasive and formative as the digital revolution. Digitalization repeatedly rewrites
More informationMetrology at NRC Canada: An NMI in an RTO Context
Metrology at NRC Canada: An NMI in an RTO Context Alan Steele NRC Measurement Science and Standards National Laboratory Association South Africa Test and Measurement Conference and Workshop September 30,
More informationPush for PM Initiative
John B. Fisher, PMP Manager Global Project Management ThyssenKrupp Elevator AG Iris Lv, PMP ThyssenKrupp Accessibility China Push for PM Initiative Guangzhou, China 1 ThyssenKrupp Elevator AG First, a
More informationSupporting Innovation through Regulation and Science
Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers
More informationDesign Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare Apps March 3, 2016 Lorraine Chapman Sr. Director of Healthcare Macadamian Jeff Belden MD Professor University of Missouri Conflict of Interest Lorraine Chapman
More informationHealth & Social Care Industrial Innovation
Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging
More informationTechnology Leadership Course Descriptions
ENG BE 700 A1 Advanced Biomedical Design and Development (two semesters, eight credits) Significant advances in medical technology require a profound understanding of clinical needs, the engineering skills
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationTHEFUTURERAILWAY THE INDUSTRY S RAIL TECHNICAL STRATEGY 2012 INNOVATION
73 INNOVATION 74 VISION A dynamic industry that innovates to evolve, grow and attract the best entrepreneurial talent OBJECTIVES Innovation makes a significant and continuing contribution to rail business
More informationWHO Regulatory Systems Strengthening Program
WHO Regulatory Systems Strengthening Program MVP RHT RSS CRS www.who.int Minimal capacity met Eligibility for vaccine PQ WHO listed NRAs WHO NRA 5 step capacity building Development of NRA benchmarking
More informationEXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA
Pan-Canadian Vision and Strategy for Health Services and Policy Research 2014 2019 EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Partners involved Alberta Cancer
More informationEnabling ICT for. development
Enabling ICT for development Interview with Dr M-H Carolyn Nguyen, who explains why governments need to start thinking seriously about how to leverage ICT for their development goals, and why an appropriate
More informationDRAFT. Cardiac Safety Research Consortium CSRC. Membership Committee Charter. 12September2018. Table of Contents
DRAFT Cardiac Safety Research Consortium CSRC Membership Committee Charter 12September2018 Table of Contents Purpose of the CSRC Membership Charter and CSRC Membership Committee Composition, Responsibilities
More information. Faye Goldman. July Contents
July 2018 Contents Background... 2 Introduction... 2 A new strategy for 2018-21... 2 Project overview... 2 Project partners... 3 Digital Product Development... 4 What we re looking for... 4 Deliverables...
More informationCDRH INNOVATION INITIATIVE. February 2011 Center for Devices and Radiological Health U.S. Food and Drug Administration
CDRH INNOVATION INITIATIVE February 2011 Center for Devices and Radiological Health U.S. Food and Drug Administration 1 Table of Contents EXECUTIVE SUMMARY... 3 BACKGROUND... 4 Innovation and Medical Device
More informationEUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020
EUROPE 2020 17-19 March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA,
More informationClimate Change Innovation and Technology Framework 2017
Climate Change Innovation and Technology Framework 2017 Advancing Alberta s environmental performance and diversification through investments in innovation and technology Table of Contents 2 Message from
More informationHigher Education Contribution to Health Science Innovation
Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28
More informationJ.P. Morgan Healthcare Conference Summary Transcript
J.P. Morgan Healthcare Conference Summary Transcript Good afternoon, everyone. I'm Shigeo Taniuchi. I'm President and COO of Santen Pharmaceutical. I joined Santen in 1996, and I became the President and
More informationHDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018
HDR UK & Digital Innovation Hubs Introduction 22 nd November 2018 Health Data Research UK s vision To create a thriving, high-energy UK-wide network of inter-disciplinary research expertise that will:
More informationWhat Works Cities Brief: The City Hall Data Gap
What Works Cities Brief: The City Hall Data Gap Yes, Using Data Can Help Cities Drive Change But Cities Need Help To Overcome the Hurdles Executive Summary Unlocking the potential of data and evidence
More informationDriving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China
Driving profitable growth in Greater China Andy Ho Chief Market Leader Greater China Key takeaways China HealthTech market is the 2 nd largest globally and exhibits continued robust growth with significant
More informationII. The mandates, activities and outputs of the Technology Executive Committee
TEC/2018/16/13 Technology Executive Committee 27 February 2018 Sixteenth meeting Bonn, Germany, 13 16 March 2018 Monitoring and evaluation of the impacts of the implementation of the mandates of the Technology
More informationImplementation in the Multilevel Context of Routine Practice and Policy
Implementation in the Multilevel Context of Routine Practice and Policy Michael K. Gould, MD, MS Director for Health Services Research and Implementation Science Department of Research and Evaluation Kaiser
More informationScience and engineering driving the global economy David Delpy, CEO May 2012
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Science and engineering driving the global economy David Delpy, CEO May 2012 A CHANGING LANDSCAPE ROYAL CHARTER - 2003 (replacing Founding Charter of
More informationWest Midlands Industrial Strategy
West Midlands Industrial Strategy May June 2018 For use by WMCA Environment Board Members and their networks 8/6/18 West Midlands Renaissance Major part of the UK economy: the largest Combined Authority
More informationNew Approaches to Safety and Risk Management
New Approaches to Safety and Risk Management 15 18 May 2011 The 3rd DIA China Annual Meeting, Bejjin, China Ayman Ayoub MD MSC (med) Safety Surveillance & Risk Management Pfizer Disclaimer The views/opinions
More informationThe case for quality
The case for quality Around the world, up to two billion people lack access to quality essential medicines. Poor-quality medicines undermine the treatment of some of the world s most pressing diseases,
More informationAgenda. Genesys Capital Partners. The Opportunity. Our Approach
MEDT Dinner Presentation September 28, 2005 Agenda Genesys Capital Partners The Opportunity Our Approach Genesys Capital Partners Genesys Capital Partners Successful Track Record Management experience
More informationUNLOCKING THE VALUE OF SASB STANDARDS
CASE STUDY UNLOCKING THE VALUE OF SASB STANDARDS SUSTAINABILITY IS CRITICAL TO OUR BUSINESS PERFORMANCE, HELPING US MITIGATE RISK, ENHANCE QUALITY, INCREASE EFFICIENCY, AND DRIVE INNOVATION. Medtronic
More informationOpen Systems Architecture in DoD Acquisition: Opportunities and Challenges
Open Systems Architecture in DoD Acquisition: Opportunities and Challenges Mr. Stephen P. Welby Deputy Assistant Secretary of Defense for Systems Engineering (DASD(SE)), OUSD(AT&L) Defense Daily 6 th Annual
More informationEXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES
EXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES EXECUTIVE BOARD MEETING METHODOLOGY FOR DEVELOPING STRATEGIC NARRATIVES 1.Context and introduction 1.1. Context Unitaid has adopted
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationDigital Health Startups A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationOpen Innovation*: Gateway to Breakthrough Ideas
1 Best Practice Guidebook Open Innovation*: Gateway to Breakthrough Ideas guidebook summary Firm: Amway Corp. (Health & Beauty Division) Industry: Consumer Goods Headquarters: Ada, Michigan, United States
More informationNEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
More informationHuman Spaceflight: The Ultimate Team Activity
National Aeronautics and Space Administration Human Spaceflight: The Ultimate Team Activity William H. Gerstenmaier Associate Administrator Human Exploration & Operations Mission Directorate Oct. 11, 2017
More information